AbbVie

ABBV · NYSE · USD

$262.82Change from previous close: +1.11%Absolute change: +$2.89

Close · October 2, 2026

At a glance

Revenue growth
+8.57%
2025 vs 2024
Net income growth
−1.22%
2025 vs 2024
Net margin
6.9%
2024: 7.6%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets135,115136,463133,960133,898137,182136,165135,161143,422141,937148,874134,711136,221
Current assets33,66933,52929,06228,53929,26127,67525,58227,78533,81638,87133,00233,224
Cash and equivalents6,5699,3915,2295,6296,4675,1755,5247,25713,13018,06712,81413,287
Short-term investments——28.042.00.01.031.028.027.02.02.03.0
Receivables13,82412,47912,58912,76912,63712,47710,91911,47211,72411,94911,15511,412
Inventory5,1275,0494,9514,9384,9604,5264,1814,4504,2184,2454,0993,981
Net property, plant and equipment5,7965,6876,3655,4835,2835,2375,8575,1415,0234,9805,7334,934
Goodwill35,51935,57035,64035,62635,63835,28534,95635,29533,38633,42632,29332,091
Other intangible assets49,13950,87352,64154,31557,03158,48960,06866,64660,24362,22555,61058,603
Long-term investments285295298358370330279267272305304275
Current liabilities41,64242,10043,28939,39139,76736,40338,74943,06241,91541,52237,84134,773
Accounts payable33,16433,5963,59233,14531,58530,7142,94530,11629,02630,9833,68829,262
Long-term debt62,53564,57258,91963,07763,06364,66260,54858,75358,35264,16252,46056,065
Total debt70,88572,91265,90165,05965,02968,43168,25071,32370,93874,356——
Total liabilities141,003143,075137,188136,497137,320134,703131,797137,351135,116140,827124,314124,092
Total equity (incl. minority)-5,888-6,612-3,228-2,599-1381,4623,3646,0716,8218,04710,39712,129
Retained earnings-17,333-17,872-15,493-14,234-11,503-9,527-7,900-4,964-3,768-2,384-1,000933
Minority interest47.044.042.043.045.042.039.039.043.040.037.035.0